Skip to main content

Table 1 Baseline characteristics of 382 HCC patients in this study

From: Ages of hepatocellular carcinoma occurrence and life expectancy are associated with a UGT2B28 genomic variation

CharacteristicValues
Gender, male, n (%)295 (77.2%)
Age at diagnosis, years, median (range)58.0 (19.0–87.0)
Tumor number, median (range)1.0 (1.0–10.0)
Capsule, n (%)280 (73.3%)
Tumor grade, median (range)3.0 (1.0–4.0)
Macrovascular invasion, n (%)41 (10.7%)
Microvascular invasion, n (%)121 (31.7%)
Tumor size, cm, median (range)4.3 (0.7–20.0)
Cirrhosis, n (%)225 (58.9%)
Ascites, n (%)26 (6.8%)
HBV alone, n (%)228 (59.7%)
HCV alone, n (%)63 (16.5%)
HBV + HCV, n (%)36 (9.4%)
NBNC, n (%)55 (14.4%)
Alcoholism (%)97 (25.4%)
UGT2B28 rs2132039 TT, n (%)181 (47.4%)
UGT2B28 rs2132039 Non-TT, n (%)201 (52.6%)
Prothrombin time, second, median (rang)11.9 (9.0–19.5)
AST, U/L, median (range)37.0 (11.0–559.0)
ALT, U/L, median (range)39.0 (7.0–749.0)
Bilirubin, mg/dL, median (range)0.8 (0.3–15.3)
Albumin, g/dL, median (range)4.1 (1.7–5.1)
Creatinine, mg/dL, median (range)1.0 (0.4–15.4)
Alpha-fetoprotein, ng/mL, median (range)26.5 (1.0–685,353.0)
Recurrent, n (%)212 (55.5%)
Recurrent time, month, median (range)12.9 (1.0–114.7)
Metastasis, n (%)73 (19.1%)
Metastatic time, month, median (range)13.0 (1.0–99.2)
Death, n (%)47 (12.3%)
Survival time, month, median (range)22.5 (0.1–73.7)
  1. Abbreviations: HBV Hepatitis B virus carrier, HCV Hepatitis C virus carrier, HBV + HCV Co-infection of hepatitis B virus and hepatitis C virus, NBNC Non-hepatitis B/hepatitis C virus carrier, AST Aspartate aminotransferase, ALT Alanine aminotransferase